HSPB1 and glioblastoma: HSPB1 protein expression levels of GBM cases with short and long survival were validated individually by western blot analysis, which showed more intense immunostaining of protein in GBM cases with short survival, confirming the possible usefulness of HSPB1 as predictive factor of worse prognosis (Fig. 3c).